Halozyme Therapeutics, Inc. First Quarter 2024 Financial & Operating Results NASDAQ: HALO May 7, 2024 1 Forward Looking Statements In addition to historical information, the statements set forth in this presentation include unexpected levels of revenues (including royalty and milestone revenue received from our forward-looking statements including, without limitation, statements concerning the collaboration partners and product sales), expenditures and costs, unexpected delays in Company’s expected future g ...